Chemokine IP-10 and Viral-Induced Demyelination
趋化因子 IP-10 和病毒引起的脱髓鞘
基本信息
- 批准号:6657924
- 负责人:
- 金额:$ 18.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Infection of susceptible mice with mouse hepatitis virus (JHMV, a positive-strand RNA virus) results in an acute encephalomyelitis following by a chronic demyelinating disease that shares many similarities with the human demyelinating disease Multiple Sclerosis (MS). Animals develop ascending hind-limb paralysis accompanied by mononuclear cell infiltration into the central nervous system (CNS) and myelin destruction. As such, the JMHV model of demyelination is a well accepted model to study the immunopathological mechanisms contributing to human demyelinating diseases such as MS. T cells and macrophages are considered important contributors to JHMV-induced demyelination as well as demyelination in MS patients. The long-range goal of this proposal is to better understand the molecular mechanisms governing the trafficking and entry of T cells into the CNS following JMHV infection. To this end, studies outlined in this research proposal are designed to evaluate the contributions of the T cell
chemoattractant chemokine IP10 (interferon inducible protein 10 kDa) in the pathogenesis of JHMV-induced demyelination. This is padicularly relevant as recent studies have implicated IP-10 as potentially important in contributing to demye!ination in MS patients by attracting T cells into the CNS. in support of this, repots from this laboratory indicate that IP-10 produced by astrocytes contributes to demyelination in JHMV-infected mice by attracting predominantly CD4+ T cells into the CNS of persistently infected mice. Specifically, antibody-mediated neutralization of IP-10 results in reduced neurologic disease, diminished demyelination, and a marked increase in the number of remyellinated axons which correlated with reduced T cell infiltration. Studies outlined in this proposal are designed to increase our understanding of how IP-10 contributes to disease in JHMV-infected mice. Novel strategies designed to accomplish this goal include (i)
examination of the molecular mechanisms contributing to IP-10 expression following either viral infection or cytokine treatment of astrocytes and (ii) examining how anti-IP-10 regulates T cell infiltration into the CNS. Together, these studies will extend our current understanding of how IP-10 controls CNS inflammation and demyelination following viral infection.
用小鼠肝炎病毒(JHMV,一种正链RNA病毒)感染易感小鼠导致急性脑脊髓炎,随后发生慢性脱髓鞘疾病,其与人类脱髓鞘疾病多发性硬化症(MS)有许多相似之处。动物发生上行性后肢麻痹,伴有单核细胞浸润到中枢神经系统(CNS)和髓鞘破坏。 因此,脱髓鞘的JMHV模型是研究有助于人类脱髓鞘疾病如MS的免疫病理学机制的公认模型。T细胞和巨噬细胞被认为是JHMV诱导的脱髓鞘以及MS患者中脱髓鞘的重要贡献者。该提案的长期目标是更好地了解JMHV感染后T细胞进入CNS的分子机制。 为此,本研究计划中概述的研究旨在评估T细胞的贡献。
趋化因子IP 10(干扰素诱导蛋白10 kDa)在JHMV诱导的脱髓鞘发病机制中的作用。这是padicularly相关的,因为最近的研究表明,IP-10作为潜在的重要贡献demye!通过将T细胞吸引到CNS中来在MS患者中进行诱导。支持这一点的是,来自该实验室的报告表明,星形胶质细胞产生的IP-10通过主要吸引CD 4 + T细胞进入持续感染小鼠的CNS而导致JHMV感染小鼠的脱髓鞘。 具体而言,抗体介导的IP-10中和导致神经疾病减少、脱髓鞘减少和与T细胞浸润减少相关的髓鞘再生轴突数量显著增加。本提案中概述的研究旨在增加我们对IP-10如何导致JHMV感染小鼠疾病的理解。为实现这一目标而设计的新战略包括:(i)
检查在病毒感染或细胞因子处理星形胶质细胞后有助于IP-10表达的分子机制,和(ii)检查抗IP-10如何调节T细胞浸润到CNS中。总之,这些研究将扩展我们目前对IP-10如何控制病毒感染后CNS炎症和脱髓鞘的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas E Lane其他文献
Thomas E Lane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas E Lane', 18)}}的其他基金
FASEB's "The Translational Neuroimmunology Conference: From Mechanisms to Therapeutics."
FASEB 的“转化神经免疫学会议:从机制到治疗学”。
- 批准号:
10065269 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Defining mechanisms of disease and repair in a viral model of multiple sclerosis
定义多发性硬化症病毒模型中的疾病和修复机制
- 批准号:
10640816 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Chemokines and Viral-Induced Neurologic Disease
趋化因子和病毒引起的神经系统疾病
- 批准号:
10090528 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Human neural precursor cell-mediated therapy in a viral model of demyelination
脱髓鞘病毒模型中的人神经前体细胞介导的治疗
- 批准号:
10076583 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:
Human neural precursor cell-mediated therapy in a viral model of demyelination
脱髓鞘病毒模型中的人神经前体细胞介导的治疗
- 批准号:
8874463 - 财政年份:2015
- 资助金额:
$ 18.27万 - 项目类别:
Viral-induced demyelination and neural stem cell-mediated remyelination
病毒诱导的脱髓鞘和神经干细胞介导的髓鞘再生
- 批准号:
8885924 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
Viral-induced demyelination and neural stem cell-mediated remyelination
病毒诱导的脱髓鞘和神经干细胞介导的髓鞘再生
- 批准号:
8799481 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
Viral-induced demyelination and neural stem cell-mediated remyelination
病毒诱导的脱髓鞘和神经干细胞介导的髓鞘再生
- 批准号:
8291218 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
Viral-induced demyelination and neural stem cell-mediated remyelination
病毒诱导的脱髓鞘和神经干细胞介导的髓鞘再生
- 批准号:
8490463 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
Viral-induced demyelination and neural stem cell-mediated remyelination
病毒诱导的脱髓鞘和神经干细胞介导的髓鞘再生
- 批准号:
8152289 - 财政年份:2011
- 资助金额:
$ 18.27万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 18.27万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 18.27万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 18.27万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 18.27万 - 项目类别:
Discovery Grants Program - Individual